Abstract | ETHNOPHARMACOLOGICAL RELEVANCE: MATERIALS AND METHOD: we investigated the anti-HBV effects of LCS in vivo and in vitro with duck hepatitis B model and HepG2.2.15 cell line model, respectively. The serologic and cellular biomarkers and the histopathological changes were examined. RESULTS: CONCLUSION: LCS exerted potent anti- hepatitis effects against the infection of HBV. The above results demonstrated the first-hand experimental evidences for the anti- hepatitis B efficiency of LCS. Our study provides a basis for further exploration and development of this promising compound prescription to treat hepatitis B disease.
|
Authors | Qing Zhao, Xia Ren, Min Chen, Shi-Jun Yue, Meng-Qi Zhang, Kai-Xian Chen, Yue-Wei Guo, Chang-Lun Shao, Chang-Yun Wang |
Journal | Journal of ethnopharmacology
(J Ethnopharmacol)
Vol. 244
Pg. 112132
(Nov 15 2019)
ISSN: 1872-7573 [Electronic] Ireland |
PMID | 31381954
(Publication Type: Journal Article)
|
Copyright | Copyright © 2019 Elsevier B.V. All rights reserved. |
Chemical References |
- Antiviral Agents
- DNA, Viral
- Drugs, Chinese Herbal
- Hepatitis B Surface Antigens
- Hepatitis B e Antigens
- Le-Cao-Shi
|
Topics |
- Animals
- Antiviral Agents
(pharmacology, therapeutic use)
- Cell Line, Tumor
- Cell Survival
(drug effects)
- DNA, Viral
- Drugs, Chinese Herbal
(therapeutic use)
- Ducks
- Hepatitis B
(drug therapy, immunology, pathology, virology)
- Hepatitis B Surface Antigens
(immunology)
- Hepatitis B Virus, Duck
(drug effects, genetics, immunology)
- Hepatitis B e Antigens
(immunology)
- Hepatitis, Viral, Animal
(drug therapy, immunology, pathology, virology)
- Humans
- Liver
(drug effects, pathology)
- Medicine, Chinese Traditional
|